SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045220
Filing Date
2024-11-14
Accepted
2024-11-13 18:00:33
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1165894
2 ex10-1.htm EX-10.1 96398
3 ex31-1.htm EX-31.1 12084
4 ex31-2.htm EX-31.2 12275
5 ex32-1.htm EX-32.1 7664
6 ex32-2.htm EX-32.2 7502
7 ex10-1_001.jpg GRAPHIC 7886
  Complete submission text file 0001493152-24-045220.txt   6048043

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE bfri-20240930.xsd EX-101.SCH 50489
9 XBRL CALCULATION FILE bfri-20240930_cal.xml EX-101.CAL 69997
10 XBRL DEFINITION FILE bfri-20240930_def.xml EX-101.DEF 245801
11 XBRL LABEL FILE bfri-20240930_lab.xml EX-101.LAB 389179
12 XBRL PRESENTATION FILE bfri-20240930_pre.xml EX-101.PRE 316472
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 773863
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 241456007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)